Oliver Juan A, Landry Donald W
Department of Medicine, Columbia University, New York, New York 10032, USA.
Curr Opin Crit Care. 2007 Aug;13(4):376-82. doi: 10.1097/MCC.0b013e3282435e16.
Vasopressin is critical for blood pressure regulation when cardiovascular homeostasis is threatened and some patients with shock have inappropriately low levels of hormone in plasma. The present review focuses on recent work that addresses the role of endogenous vasopressin in the pathogenesis of shock and the potential therapeutic indications and secondary effects of exogenous hormone in patients with shock.
Examples of types of shock resistant to catecholamine pressors in which exogenous vasopressin was effective in restoring arterial pressure continued to accumulate. Widespread determinations of plasma vasopressin in patients with shock suggest that endogenous vasopressin deficiency may be more frequent than previously thought. The generation of mice with deletion of vasopressin's V1a receptor highlighted the important role of the hormone on cardiovascular homeostasis.
Vasopressin administration is very effective in restoring arterial pressure in many forms of shock and this appears to be due, at least in part, to deficiency of endogenous hormone. Generation of mice lacking vasopressin V1a receptor open new and exciting avenues of inquiry to clarify the role of the hormone in cardiovascular homeostasis.
当心血管稳态受到威胁时,血管加压素对血压调节至关重要,一些休克患者血浆中激素水平异常低下。本综述聚焦于近期研究,这些研究探讨了内源性血管加压素在休克发病机制中的作用,以及外源性激素在休克患者中的潜在治疗指征和副作用。
外源性血管加压素能有效恢复动脉压的抗儿茶酚胺升压药的休克类型实例不断增加。对休克患者血浆血管加压素的广泛测定表明,内源性血管加压素缺乏可能比以前认为的更为常见。血管加压素V1a受体缺失小鼠的产生凸显了该激素对心血管稳态的重要作用。
血管加压素给药在多种形式的休克中恢复动脉压非常有效,这似乎至少部分归因于内源性激素缺乏。缺乏血管加压素V1a受体小鼠的产生为阐明该激素在心血管稳态中的作用开辟了新的、令人兴奋的研究途径。